The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The E-screen assay: a comparison of different MCF7 cell stocks.
Open accessAbstract
MCF7 human breast cancer cells have been studied extensively as a model for hormonal effects on breast cancer cell growth and specific protein synthesis. Because the proliferative effect of natural estrogen is considered the hallmark of estrogen action, it was proposed that this property be used to determine whether a substance is an estrogen. The E-screen assay, developed for this purpose, is based on the ability of MCF7 cells to proliferate in the presence of estrogens. The aim of our study was to characterize the response of four MCF7 cell stocks (BUS, ATCC, BB, and BB104) and determine which of them performed best in the E-screen test. The four stocks assayed were distinguishable by their biological behavior. In the absence of estrogen, MCF7 BUS cells stopped proliferating and accumulated in the G0/G1 phase of the cell cycle; estrogen receptors increased, progesterone receptors decreased, and small amounts of pS2 protein were secreted. Of all the MCF7 stocks tested, MCF7 BUS cells showed the highest proliferative response to estradiol-17 beta: cell yields increased up to sixfold over those of nontreated cells in a 144-hr period. The differences between estrogen-supplemented and nonsupplemented MCF7 BUS cells were due mostly to G0/G1 proliferative arrest mediated by charcoal dextran-stripped serum. MCF7 BUS cell stocks and others showing a similar proliferative pattern should be chosen for use in the E-screen test, or whenever a proliferative effect of estrogen is to be demonstrated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., & Boyd, M. R. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1107 · Cited by 9,766
A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Soule, H. D., Vazquez, J., Long, A., Albert, S., & Brennan, M. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1409 · Cited by 2,449
Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving
Krishnan, A. V., Stathis, P., Permuth, S. F., Tokes, L., & Feldman, D. I. (1993) · Endocrinology · doi:10.1210/en.132.6.2279 · Cited by 1,613
Environmentally persistent alkylphenolic compounds are estrogenic
White, R., Jobling, S., Hoare, S., Sumpter, J. P., & Parker, M. G. (1994) · Endocrinology · doi:10.1210/en.135.1.175 · Cited by 1,451
Berthois, Y., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2496 · Cited by 1,307
p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene.
Soto, A. M., Justicia, H., Wray, J. W., & Sonnenschein, C. (1991) · Environmental Health Perspectives · doi:10.1289/ehp.9192167 · Cited by 1,082
Katzenellenbogen, B. S., Kendra, K. L., Norman, M. J., & Berthois, Y. (1987) · PubMed · Cited by 403
Karey, K. P., & Sirbasku, D. A. (1988) · PubMed · Cited by 327
Katzenellenbogen, B. S., Norman, M. J., Eckert, R. L., Peltz, S. W., & Mangel, W. F. (1984) · PubMed · Cited by 276
Biological differences among MCF-7 human breast cancer cell lines from different laboratories
Osborne, C. K., Hobbs, K., & Trent, J. M. (1987) · Breast Cancer Research and Treatment · doi:10.1007/bf01807363 · Cited by 272
The role of estrogens on the proliferation of human breast tumor cells (MCF-7)
Soto, A. M., & Sonnenschein, C. (1985) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(85)90265-1 · Cited by 253
Arteaga, C. L., Tandon, A. K., Hoff, D. D. V., & Osborne, C. K. (1988) · PubMed · Cited by 245
An"in culture"bioassay to assess the estrogenicity of xenobiotics (E-SCREEN)
Soto, A. M. (1992) · Medical Entomology and Zoology · Cited by 212
Growth of a human mammary tumour cell line in a serum-free medium
Barnes, D., & Sato, G. (1979) · Nature · doi:10.1038/281388a0 · Cited by 176
Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells.
Lottering, M.-L., Haag, M., & Seegers, J. C. (1992) · PubMed · Cited by 142
Pratt, S. E., & Pollak, M. (1993) · PubMed · Cited by 118
Zajchowski, D. A., Sager, R., & Webster, L. (1993) · PubMed · Cited by 113
Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7.
Pagé, M., Field, J. K., Everett, N. P., & Green, C. D. (1983) · PubMed · Cited by 105
Taylor, C. M., Blanchard, B., & Zava, D. T. (1984) · PubMed · Cited by 99
Resnicoff, M., Medrano, E. E., Podhajcer, O. L., Bravo, A., Bover, L. C., & Mordoh, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7295 · Cited by 81
Catecholestrogens are MCF-7 cell estrogen receptor agonists
Schütze, N., Vollmer, G., Tiemann, I., Geiger, M., & Knüppen, R. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90319-r · Cited by 76
Reddel, R. R., & Sutherland, R. L. (1987) · PubMed · Cited by 62
Pr, B., Wilton, J., Jones, C., et al. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.115 · Cited by 60
van der Burg, B., Kalkhoven, E., Isbrücker, L., & de Laat, S. W. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90257-j · Cited by 58
Butler, W. B., Berlinski, P. J., Hillman, R. M., Kelsey, W. H., & Toenniges, M. M. (1986) · PubMed · Cited by 56
Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line
Natoli, C., Sica, G., Natoli, V., Serra, A., & Iacobelli, S. (1983) · Breast Cancer Research and Treatment · doi:10.1007/bf01806231 · Cited by 44
Cytogenetic Studies of Human Breast Cancer Lines: MCF-7 and Derived Variant Sublines
Whang‐Peng, J., Lee, E. C., Kao-Shan, C. S., Seibert, K., & Lippman, M. E. (1983) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/71.4.687 · Cited by 44
Bezwoda, W. R., & Meyer, K. L. (1990) · PubMed · Cited by 40
Ruedl, C., Cappelletti, V., Coradini, D., Granata, G., & di Fronzo, G. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90327-h · Cited by 33
Calvo, F. M., Brower, M., & Carney, D. N. (1984) · PubMed · Cited by 32
Zugmaier, G., Knabbe, C., Fritsch, C., Simpson, S., Ennis, B. W., Lippman, M. E., & Dickson, R. B. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90367-e · Cited by 17
Cited by
Métivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431
Soares, A., Guieysse, B., Jefferson, B., Cartmell, E., & Lester, J. N. (2008) · Environment International · doi:10.1016/j.envint.2008.01.004 · Cited by 1,172
Thyroid Hormone Action Is Disrupted by Bisphenol A as an Antagonist
Moriyama, K., Tagami, T., Akamizu, T., Usui, T., Saijo, M., Kanamoto, N., Hataya, Y., Shimatsu, A., Kuzuya, H., & Nakao, K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020209 · Cited by 812
Raun Andersen, H., Vinggaard, A. M., Høj Rasmussen, T., Gjermandsen, I. M., & Cecilie Bonefeld-Jørgensen, E. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9347 · Cited by 603
Bisphenol A interacts with the estrogen receptor α in a distinct manner from estradiol
Gould, J. C., Leonard, L. S., Maness, S. C., Wagner, B. L., Conner, K., Zacharewski, T., Safe, S., McDonnell, D. P., & Gaido, K. W. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00084-7 · Cited by 510
Metadata
- Authors
- Villalobos, M., Olea, N., Brotons, J. A., Olea-Serrano, M. F., Ruiz de Almodovar, J. M., & Pedraza, V
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 1995-09
- Volume
- 103
- Issue
- 9
- Pages
- 844-850
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2037815393
- Cited by
- 263
- References
- 31
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.